"Vitamins and Dietary Supplements in Belgium" now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Fri Aug 01 2014

Whilst opinions differed on the fortunes of vitamins and dietary supplements in 2011, industry consensus was that the whole category was in a state of crisis in 2012. From 14 December 2012, the regulatory environment for vitamins and dietary supplements was set to become stricter, with new regulation of health claims. Thus, during the whole of 2012, players were on the home straight in terms of conforming to the new EFSA (European Food Safety Authority) regulation. In addition, trade sources observed that products which used to drive growth before the crisis were more or less reaching maturity. Other than probiotics and glucosamine, this was notably the case for single substances such as mineral supplements, which saw static current value sales in 2012. It seemed that the hype for pure mineral products such as magnesium lessened in 2012, notably due to the cannibalisation by calming and sleeping.

Full Report Details at
- http://www.fastmr.com/prod/841515_vitamins_and_dietary_supplements_in_belgium.aspx?afid=304

Competitive Landscape

The competitive environment for vitamins and dietary supplements remained fragmented in 2012, with the top five GBOs securing a 35% share of value sales. This was concomitant with the presence of players from different backgrounds and countries, and positioned in various distribution channels. Merck was the only player with a double-digit value share, of 14% in 2012. Merck's strong diversification policy, its focus on doctors and pharmacists through its sales force and press communications, and the breakthrough of its Omnibionta 3 and Bion umbrella brands paid off in recent years. With these brands, Merck was a forerunner in the area of multivitamins and dietary supplements with probiotics.

Industry Prospects

From 14 December 2012, many brands will have to adjust to the EFSA (European Food Safety Authority) legislation. It notably states that the active ingredient must account for at least 15% of the Recommended Daily Intake. Manufacturers will have to indicate for each brand variant the necessary dose to be efficient, the effects, and proof of its efficiency with tests and studies. If not, some products could be forced to revise their claims and names if they convey a false or exaggerated image. In such cases, players may have to depend on high brand equity to offset the impact of the legislation. Mainstream manufacturers, often multinationals which are also present in OTC products, have anticipated the great changes of 14 December, but not many small players. This is expected to result in the withdrawal of many brand variants in early 2013 - for those that will be immediately banned - and slightly later for those that will have changes to their name, but will lack the recognition and image to survive.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Vitamins and Dietary Supplements industry in Belgium with research from Euromonitor's team of in-country analysts.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Vitamins and Dietary Supplements in Iran
- Vitamins and Dietary Supplements in Finland
- Vitamins and Dietary Supplements in South Korea
- Vitamins and Dietary Supplements in Canada
- Vitamins and Dietary Supplements in Dominican Republic
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »